{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:10:27Z","timestamp":1761887427843,"version":"build-2065373602"},"reference-count":170,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.nrleng.2019.03.027","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T02:45:03Z","timestamp":1621910703000},"page":"480-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Degenerative dementias: a question of syndrome or disease?"],"prefix":"10.1016","volume":"37","author":[{"given":"A.","family":"Robles Bay\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2019.03.027_bib0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0010","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer\u2019s disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancetr Neurol."},{"year":"2013","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","key":"10.1016\/j.nrleng.2019.03.027_bib0015"},{"key":"10.1016\/j.nrleng.2019.03.027_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0891988716656083","article-title":"Revisiting DLB diagnosis: a consideration of prodromal DLB and of the diagnostic overlap with Alzheimer disease","volume":"29","author":"McKeith","year":"2016","journal-title":"J Geriatr Psychiatry Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0025","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1016\/j.neurobiolaging.2015.07.019","article-title":"Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates","volume":"36","author":"Borroni","year":"2015","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fneur.2018.00504","article-title":"CSF biomarkers of neurodegeneration in progressive non-fluent aphasia and other forms of frontotemporal dementia: clues for pathomechanisms?","volume":"9","author":"K\u00f6rtvelyessy","year":"2018","journal-title":"Front Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2017.10.016","article-title":"Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study","volume":"62","author":"Galimberti","year":"2018","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171524","article-title":"Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer\u2019s disease: an autopsy-confirmed study","volume":"12","author":"Morimoto","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nrleng.2019.03.027_bib0055","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/mds.111","article-title":"\u03b1-synuclein species as potential cerebrospinal fluid biomarkers for dementia with Lewy bodies","volume":"33","author":"van Steenoven","year":"2018","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0060","doi-asserted-by":"crossref","first-page":"e1619","DOI":"10.1212\/WNL.0000000000006383","article-title":"CSF sAPP\u03b2, YKL\u201440, and NfL along the ALS-FTD spectrum","volume":"91","author":"Ill\u00e1n-Gala","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0065","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1007\/s12035-018-1313-4","article-title":"Cerebrospinal fluid total and phosphorylated \u03b1-synuclein in patients with Creutzfeldt-Jakob disease and synucleinopathy","volume":"56","author":"Schmitz","year":"2019","journal-title":"Mol Neurobiol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0070","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/brain\/awh598","article-title":"The evolution and pathology of frontotemporal dementia","volume":"128","author":"Kertesz","year":"2005","journal-title":"Brain."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0075","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/2013.jamaneurol.79","article-title":"Differential diagnosis of Jakob-Creutzfeldt disease","volume":"69","author":"Paterson","year":"2012","journal-title":"Arch Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0080","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awx254","article-title":"Clinicopathological correlations in behavioural variant frontotemporal dementia","volume":"140","author":"Perry","year":"2017","journal-title":"Brain."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0085","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0090","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0095","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-2012-111400","article-title":"Co-occurrence of different pathologies in dementia: implications for dementia diagnosis","volume":"30","author":"Ech\u00e1varri","year":"2012","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer\u2019s Disease Centers, 2005-2010","volume":"71","author":"Beach","year":"2012","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-132465","article-title":"Initial Diagnoses of patients ultimately diagnosed with prion disease","volume":"42","author":"Appleby","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-014-1251-9","article-title":"The widening spectrum of C9ORF72-related disease; genotype\/phenotype correlations and potential modifiers of clinical phenotype","volume":"127","author":"Cooper-Knock","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnagi.2015.00171","article-title":"Phenotypic heterogeneity of monogenic frontotemporal dementia","volume":"7","author":"Benussi","year":"2015","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0120","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jalz.2017.01.014","article-title":"Consensus classification of posterior cortical atrophy","volume":"13","author":"Crutch","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neurobiolaging.2015.09.023","article-title":"Evaluating pathogenic dementia variants in posterior cortical atrophy","volume":"37","author":"Carrasquillo","year":"2016","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0004-282X2011000300029","article-title":"Huntington\u2019s disease presenting as posterior cortical atrophy","volume":"69","author":"Caixeta","year":"2011","journal-title":"Arq Neuropsiquiatr."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0135","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223108","article-title":"Down syndrome with posterior cortical atrophy","author":"Boutoleau-Bretonni\u00e8re","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrneurol.2009.216","article-title":"Primary progressive aphasia: clinicopathological correlations","volume":"6","author":"Grossman","year":"2010","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00415-014-7243-9","article-title":"Progranulin-associated PiB-negative logopenic primary progressive aphasia","volume":"261","author":"Josephs","year":"2014","journal-title":"J Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0150","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/WAD.0b013e318260ab27","article-title":"Sporadic Creutzfeldt-Jakob disease presenting as progressive nonfluent aphasia with speech apraxia","volume":"27","author":"Kobylecki","year":"2013","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00401-015-1442-z","article-title":"Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with \u03b1-synuclein","volume":"130","author":"Aoki","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0160","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2169\/internalmedicine.8462-16","article-title":"CSF1R mutation p.G589R and the distribution pattern of brain calcification","volume":"56","author":"Daida","year":"2017","journal-title":"Intern Med."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0165","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1212\/WNL.0b013e3181bd82a7","article-title":"\u201cFrontotemporoparietal\u201d dementia: clinical phenotype associated with the c.709-1G&A PGRN mutation","volume":"73","author":"Moreno","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1533317507302320","article-title":"Progressive nonfluent aphasia associated with a new mutation V363I in tau gene","volume":"22","author":"Munoz","year":"2007","journal-title":"Am J Alzheimers Dis Other Demen."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-150203","article-title":"Progressive supranuclear palsy syndrome and semantic dementia in neuropathologically proven Lewy body disease: a report of two cases","volume":"47","author":"Lagarde","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13195-016-0219-5","article-title":"An update on semantic dementia: genetics, imaging, and pathology","volume":"8","author":"Land\u00edn-Romero","year":"2016","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jamda.2009.03.007","article-title":"Apathy: a common psychiatric syndrome in the elderly","volume":"10","author":"Ishii","year":"2009","journal-title":"J Am Med Dir Assoc."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cortex.2018.03.019","article-title":"Apathy in Alzheimer\u2019s disease and frontotemporal dementia: distinct clinical profiles and neural correlates","volume":"103","author":"Kumfor","year":"2018","journal-title":"Cortex."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0195","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/mds.22843","article-title":"Apathy may herald cognitive decline and dementia in Parkinson\u2019s disease","volume":"24","author":"Dujardin","year":"2009","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1176\/appi.neuropsych.17010012","article-title":"Use of the Neuropsychiatric Inventory to characterize the course of neuropsychiatric symptoms in progressive supranuclear palsy","volume":"30","author":"Je\u010dmenica-Luki\u0107","year":"2018","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/psyg.12054","article-title":"Corticobasal degeneration initially developing motor versus non-motor symptoms: a comparative clinicopathological study","volume":"14","author":"Ikeda","year":"2014","journal-title":"Psychogeriatrics."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0210","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/brain\/awv358","article-title":"Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort","volume":"139","author":"Van Mossevelde","year":"2016","journal-title":"Brain."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0215","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4172\/2161-0460.1000431","article-title":"Apathy in Huntington\u2019s disease: a review of the current conceptualization","volume":"8","author":"Camacho","year":"2018","journal-title":"J Alzheimers Dis Parkinsonism."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0220","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/jnnp-2017-316864","article-title":"Establishing diagnostic criteria for Perry syndrome","volume":"89","author":"Mishima","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/alzrt141","article-title":"Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease","volume":"4","author":"Takada","year":"2012","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0230","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/neup.12441","article-title":"Frontotemporal lobar degeneration due to P301L tau mutation showing apathy and severe frontal atrophy but lacking other behavioral changes: a case report and literatura review","volume":"38","author":"Miki","year":"2018","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0235","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1752-1947-2-331","article-title":"Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series","volume":"2","author":"Ye","year":"2008","journal-title":"J Med Case Rep."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3233\/JAD-150863","article-title":"PRNP P39L variant is a rare cause of frontotemporal dementia in Italian population","volume":"50","author":"Oldoni","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0245","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1212\/WNL.0b013e3181d52785","article-title":"Worldwide distribution of PSEN1 Met146Leu mutation","volume":"74","author":"Bruni","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2016.12.002","article-title":"Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene","volume":"35","author":"Bougea","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0255","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1212\/WNL.0b013e3182815547","article-title":"Clinicopathologic differences among patients with behavioral variant frontotemporal dementia","volume":"80","author":"Mendez","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/psyg.12143","article-title":"Sexual disinhibition and dementia","volume":"16","author":"Cipriani","year":"2016","journal-title":"Psychogeriatrics."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0265","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awv191","article-title":"The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: clinical, neuroimaging and pathological features","volume":"138","author":"Ossenkoppele","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-1789.2005.00598.x","article-title":"Argyrophilic grain disease presenting with frontotemporal dementia: a neuropathological and pathological study of an autopsied case with presenile onset","volume":"25","author":"Ishihara","year":"2005","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0275","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neurol.2016.07.009","article-title":"Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations","volume":"172","author":"Eusebio","year":"2016","journal-title":"Rev Neurol (Paris)."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0280","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/13554794.2011.627345","article-title":"Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia","volume":"18","author":"Hassan","year":"2012","journal-title":"Neurocase."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0285","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1176\/appi.ajp.2016.16020240","article-title":"Identification of two heritable cross-disorder endophenotypes for Tourette syndrome","volume":"174","author":"Darrow","year":"2017","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0290","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/jnp.2010.22.2.196","article-title":"\u201cFrontal\u201d behaviors before the diagnosis of Huntington\u2019s disease and its relationship to markers of disease progression: evidence of early lack of awareness","volume":"22","author":"Duff","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jnc.13654","article-title":"The clinical spectrum of sporadic and familial forms of frontotemporal dementia","volume":"138(suppl 1)","author":"Woollacott","year":"2016","journal-title":"J Neurochem."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/arclin\/acs098","article-title":"Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy","volume":"28","author":"Gerstenecker","year":"2013","journal-title":"Arch Clin Neuropsychol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0305","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000087299","article-title":"Cognitive impairment in the lateralized phenotype of corticobasal degeneration","volume":"20","author":"Moretti","year":"2005","journal-title":"Dement Cogn Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0310","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1468-1331.2012.03669.x","article-title":"Cognitive and affective impairments of a novel SCA\/MND crossroad mutation Asidan","volume":"19","author":"Abe","year":"2012","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0315","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","article-title":"The frontotemporal dementia-motor neuron disease continuum","volume":"388","author":"Burrell","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0320","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2010.08.013","article-title":"Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss","volume":"298","author":"Kobayashi","year":"2010","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0325","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1468-1331.2007.01759.x","article-title":"Amyotrophic lateral sclerosis and Alzheimer\u2019s disease. Clinical and neuropathological considerations in two cases","volume":"14","author":"Rusina","year":"2007","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0330","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jns.2016.10.038","article-title":"Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report","volume":"372","author":"Yaguchi","year":"2017","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0335","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1212\/WNL.0000000000000778","article-title":"Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders","volume":"83","author":"Lattante","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0340","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3181f07e0c","article-title":"Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS\/dementia","volume":"75","author":"Yan","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0345","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","article-title":"Coexistence of Huntington\u2019s disease and amyotrophic lateral sclerosis: a clinicopathologic study","volume":"124","author":"Tada","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0350","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/17482968.2012.678365","article-title":"Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation","volume":"13","author":"Katz","year":"2012","journal-title":"Amyotroph Lateral Scler."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00401-015-1431-2","article-title":"A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration","volume":"130","author":"Nakamura","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0360","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/s1980-5764-2016dn1004004","article-title":"Cognitive dysfunction in hereditary spastic paraplegias and other motor neuron disorders","volume":"10","author":"Faber","year":"2016","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0365","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1582-4934.2011.01311.x","article-title":"Cerebral correlates of psychotic syndromes in neurodegenerative diseases","volume":"16","author":"Jellinger","year":"2012","journal-title":"J Cell Mol Med."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0370","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1017\/S0317167100013421","article-title":"Clinical overlap between Jakob-Creutzfeldt disease and Lewy body disease","volume":"39","author":"Tartaglia","year":"2012","journal-title":"Can J Neurol Sci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0375","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1176\/appi.neuropsych.16090168","article-title":"Psychiatric presentations of C9orf72 mutation: what are the diagnostic implications for clinicians?","volume":"29","author":"Ducharme","year":"2017","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0380","first-page":"73","article-title":"Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights","volume":"6","author":"Ostergaard","year":"2016","journal-title":"Degener Neurol Neuromuscul Dis."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0385","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5320135","article-title":"The association between 5HT2A T102C and behavioral and psychological symptoms of dementia in Alzheimer\u2019s disease: a meta-analysis","volume":"2017","author":"Tang","year":"2017","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0390","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/03007995.2017.1294054","article-title":"The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease","volume":"33","author":"Hendriksz","year":"2017","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0395","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neubiorev.2014.02.010","article-title":"Familial Alzheimer\u2019s disease sustained by presenilin 2 mutations: systematic review of literature and genotype-phenotype correlation","volume":"42","author":"Canevelli","year":"2014","journal-title":"Neurosci Biobehav Rev."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.13001","article-title":"New perspective on Parkinsonism in frontotemporal lobar degeneration","volume":"6","author":"Park","year":"2013","journal-title":"J Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0405","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1590\/0004-282X20140127","article-title":"Cognition in a multiple system atrophy series of cases from Argentina","volume":"72","author":"Gatto","year":"2014","journal-title":"Arq Neuropsiquiatr."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0410","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/mds.20547","article-title":"Parkinsonism-dementia complex of Guam","volume":"20 (suppl 12)","author":"Steele","year":"2005","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0415","doi-asserted-by":"crossref","first-page":"675","DOI":"10.33588\/rn.3807.2003542","article-title":"Heterogeneidad cl\u00ednica de la enfermedad de Alzheimer. Diferentes perfiles cl\u00ednicos pueden predecir el intervalo de progresi\u00f3n","volume":"38","author":"Mangone","year":"2004","journal-title":"Rev Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0420","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00415-012-6752-7","article-title":"MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy","volume":"260","author":"Petrovic","year":"2013","journal-title":"J Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0425","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/brain\/awf086","article-title":"Guadaloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy","volume":"125","author":"Caparros-Lefebvre","year":"2002","journal-title":"Brain."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0430","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/mds.22675","article-title":"Hereditary Parkinsonism: Parkinson disease look-alikes. An algorithm for clinicians to \u201cPARK\u201d genes and beyond","volume":"24","author":"Klein","year":"2009","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0435","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1590\/S1980-57642009DN30100004","article-title":"Cognitive impairment in Wilson\u2019s disease","volume":"3","author":"Ferreira Frota","year":"2009","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0440","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.parkreldis.2017.06.004","article-title":"DCTN1-related neurodegeneration: Perry syndrome and beyond","volume":"41","author":"Konno","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0445","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/mds.21493","article-title":"Fragile X-associated tremor\/ataxia syndrome: clinical features, genetics, and testing guidelines","volume":"22","author":"Berry-Kravis","year":"2007","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0450","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.parkreldis.2008.08.004","article-title":"Glucosidase-beta variations and Lewy body disorders","volume":"15","author":"Farrer","year":"2009","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0455","first-page":"696953","article-title":"Atypical parkinsonism revealing a late onset, rigid and akinetic form of Huntington\u2019s disease","volume":"2011","author":"Ciammola","year":"2011","journal-title":"Case Rep Neurol Med."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0460","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2016.11.050","article-title":"Huntington\u2019s disease like 2 presenting with isolated Parkinsonism","volume":"373","author":"Vasconcellos","year":"2017","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0465","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.parkreldis.2016.07.015","article-title":"LRRK2 variation and dementia with Lewy bodies","volume":"31","author":"Heckman","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0470","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.b.32505","article-title":"Genetic prion disease: Experience of a rapidly progressive dementia Center in the United States and a review of the literature","volume":"174","author":"Takada","year":"2017","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0475","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.22424","article-title":"Clinicopathological correlations in corticobasal degeneration","volume":"70","author":"Lee","year":"2011","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0480","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awq123","article-title":"Does corticobasal degeneration exist? A clinicopathological re-evaluation","volume":"133","author":"Ling","year":"2010","journal-title":"Brain."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0485","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/13854046.2016.1259434","article-title":"Corticobasal syndrome due to sporadic Creutzfeldt-Jakob disease: a review and neuropsychological case report","volume":"31","author":"Gonz\u00e1lez","year":"2017","journal-title":"Clin Neuropsychol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153852","article-title":"Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal Lobar degeneration: a systematic review and meta-analysis","volume":"11","author":"Gasca-Salas","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0495","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jalz.2016.08.014","article-title":"Characterizing familial corticobasal syndrome due to Alzheimer\u2019s disease pathology and PSNE1 mutations","volume":"13","author":"Lam","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0500","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/brain\/awh265","article-title":"Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy","volume":"127","author":"Paviour","year":"2014","journal-title":"Brain."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2017.10.010","article-title":"Beyond ALS and FTD: the phenotypic spectrum of TBK1 mutations includes PSP-like and cerebellar phenotypes","volume":"62","author":"Wilke","year":"2018","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0510","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/S0004-282X2011000400002","article-title":"Clinical and genetic analysis of 29 Brazilian patients with Huntington\u2019s disease-like phenotype","volume":"69","author":"Rodrigues","year":"2011","journal-title":"Arq Neuropsiquiatr."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0515","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/mdc3.12312","article-title":"Huntington\u2019s disease, Huntington\u2019s disease look-alikes, and benign hereditary chorea","volume":"3","author":"Schneider","year":"2016","journal-title":"What\u2019s new? Mov Disord Clin Pract."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0520","unstructured":"Veneziano L, Frontali M. DRPLA. En: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editores. Gene Reviews. Seattle, WA: University of Washington, Seattle; 1993\u20132018."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0525","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jns.2018.04.031","article-title":"A study of Huntington disease-like syndromes in black South African patients reveals a single SCA2 mutation and a unique distribution of normal alleles across five repeat loci","volume":"390","author":"Baine FKm Peerbhai","year":"2018","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0530","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2016.12.010","article-title":"New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients","volume":"36","author":"Vroegindeweij","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0535","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5334\/tohm.317","article-title":"Neuroferritinopathy: pathophysiology, presentation, differential diagnosis and management","volume":"6","author":"Kumar","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0540","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5334\/tohm.246","article-title":"Mutation in GM2A leads to a progressive chorea-dementia syndrome","volume":"5","author":"Salih","year":"2015","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0545","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.26679","article-title":"Huntington\u2019s disease-like presentation in spinocerebellar ataxia type 12","volume":"31","author":"Groppo","year":"2016","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0550","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.0000000000001521","article-title":"RNF216 mutations as a novel cause of autosomal recessive Huntington-like disorder","volume":"84","author":"Santens","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0555","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/mds.22697","article-title":"TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea","volume":"24","author":"Kovacs","year":"2009","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0560","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JAD-180018","article-title":"Frontotemporal dementia and chorea associated with a compound heterozygous TREM2 mutation","volume":"63","author":"Redaelli","year":"2008","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0565","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acn3.511","article-title":"Xeroderma pigmentosum is a definite cause of Huntington\u2019s disease-like syndrome","volume":"5","author":"Garcia-Moreno","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0570","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clineuro.2017.10.039","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy","volume":"164","author":"Barcelos","year":"2018","journal-title":"Clin Neurol Neurosurg."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0575","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/jnnp.2006.088930","article-title":"Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK","volume":"77","author":"Cooper","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0580","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40673-015-0035-x","article-title":"Mitochondrial pathology in progressive cerebellar ataxia","volume":"2","author":"Bargiela","year":"2015","journal-title":"Cerebellum Ataxias."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0585","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mds.26499","article-title":"Cerebellar ataxia in progressive supranuclear palsy: an autopsy study of PSP-C","volume":"31","author":"Koga","year":"2016","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0590","first-page":"135","article-title":"Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype","volume":"1271","author":"Morgan-Hughes","year":"1995","journal-title":"Biochem Biophys Acta."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0595","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.parkreldis.2017.06.010","article-title":"Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors","volume":"42","author":"Monte","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0600","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.eplepsyres.2014.08.017","article-title":"Late onset Lafora disease and novel EPM2A mutations: breaking paradigms","volume":"108","author":"Jara-Prado","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0605","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1136\/jmg.2005.039479","article-title":"Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora\u2019s progressive myoclonic epilepsy","volume":"43","author":"Singh","year":"2006","journal-title":"J Med Genet."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0610","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","article-title":"Degeneration of the cerebellum in Huntington\u2019s disease (HD): Possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process","volume":"23","author":"R\u00fcb","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0615","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.68.3.388","article-title":"Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia","volume":"68","author":"Taniwaki","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0620","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/brain\/124.10.1939","article-title":"CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia","volume":"124","author":"Fujigasaki","year":"2001","journal-title":"Brain."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0625","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1212\/01.WNL.0000125192.69777.6D","article-title":"Autonomic dysfunction in dementia with Lewy bodies","volume":"62","author":"Thaisetthawatkul","year":"2004","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045451","article-title":"The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson\u2019s disease with dementia","volume":"7","author":"Stubendorff","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0635","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-140531","article-title":"The phoenix from the ashes: cardiovascular autonomic dysfunction in behavioral variant of frontotemporal dementia","volume":"42","author":"Struhal","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0640","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2169\/internalmedicine.36.492","article-title":"Creutzfeldt-Jakob disease associated with autonomic nervous system dysfunction in the early stage","volume":"36","author":"Nomura","year":"1997","journal-title":"Internal Med."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0645","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1981.00510020072011","article-title":"Autonomic dysfunction in subacute spongiform encephalopathy","volume":"38","author":"Khurana","year":"1981","journal-title":"Arch Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0650","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/jnnp.72.6.726","article-title":"Autonomic nervous system function in Huntington\u2019s disease","volume":"72","author":"Andrich","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0655","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJMoa1214747","article-title":"A novel prion disease associated with diarrhea and autonomic neuropathy","volume":"369","author":"Mead","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0660","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/19336896.2016.1243192","article-title":"An autopsy-verified case of FTLD-TDP type A with upper motor neuron-predominant motor neuron disease mimicking MM2-thalamic-type sporadic Creutzfeldt-Jakob disease","volume":"10","author":"Hayashi","year":"2016","journal-title":"Prion."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0665","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/NEN.0b013e31820cd8a4","article-title":"Comprehensive neuropathologic analysis of genetic prion disease associated with the E196K mutation in PRNP reveals phenotypic heterogeneity","volume":"70","author":"Eigenbrod","year":"2011","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0670","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000161560","article-title":"Mixed brain pathologies in dementia: the BrainNet Europe Consortium Experience","volume":"26","author":"Kovacs","year":"2008","journal-title":"Dement Geriatr Cogn Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0675","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0680","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-004-0933-0","article-title":"Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?","volume":"109","author":"Tan","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0685","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trci.2016.09.002","article-title":"Multiple comorbid neuropathologies in the setting of Alzheimer\u2019s disease neuropathology and implications for drug development","volume":"3","author":"Rabinovici","year":"2017","journal-title":"Alzheimers Dement (N Y)."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0690","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14802\/jmd.10003","article-title":"Clinicopathological correlates of Lewy body disease: fundamental issues","volume":"3","author":"Ahn","year":"2010","journal-title":"J Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0695","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00401-005-0022-z","article-title":"Coexistence of PSP and MSA: a case report and review of the literature","volume":"111","author":"Uchikado","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0700","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JHD-140111","article-title":"The co-occurrence of Alzheimer\u2019s disease and Huntington\u2019s disease: a neuropathological study of 15 elderly Huntington\u2019s disease subjects","volume":"3","author":"Davis","year":"2014","journal-title":"J Huntingtons Dis."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0705","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","article-title":"Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease","volume":"67","author":"Schwab","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0710","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/mds.22204","article-title":"Association of corticobasal degeneration and Huntington\u2019s disease: can tau aggregates protect huntingtin toxicity?","volume":"24","author":"Caparros-Lefebvre","year":"2009","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0715","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/neup.12150","article-title":"Coexistence of mixed phenotype Creutzfeldt-Jakob disease, Lewy body disease and argyrophilic grain disease plus histological features of possible Alzheimer\u2019s disease: a multi-protein disorder in an autopsy case","volume":"35","author":"Fern\u00e1ndez-Vega","year":"2015","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0720","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/neup.12343","article-title":"Patient with rapidly evolving neurological disease with neuropathological lesions of Creutzfeldt-Jakob disease, Lewy body dementia, chronic subcortical vascular encephalopathy and meningothelial meningioma","volume":"37","author":"Vita","year":"2017","journal-title":"Neuropathology"},{"key":"10.1016\/j.nrleng.2019.03.027_bib0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2016.09.021","article-title":"Analysis of the prion protein gene in multiple system atrophy","volume":"49","author":"Chelban","year":"2017","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0730","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/neup.12429","article-title":"Neuropathological comorbidity associated with argyrophilic grain disease","volume":"38","author":"Yokota","year":"2018","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0735","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3233\/JAD-171115","article-title":"Argyrophilic grain pathology in frontotemporal lobar degeneration: Demgraphic, clinical, neuropathological, and genetic features","volume":"63","author":"Gil","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0740","first-page":"433","article-title":"Occurrence of argyrophilic grains in multiple system atrophy: histopathological examination of 26 autopsy cases","volume":"51","author":"Wakabayashi","year":"1999","journal-title":"No To Shinkei."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0745","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/neup.12192","article-title":"Atypical sporadic CJD-MM phenotype with white matter kuru plaques associated with intranuclear inclusion body and argyrophilic grain disease","volume":"35","author":"Berghoff","year":"2015","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0750","doi-asserted-by":"crossref","first-page":"60","DOI":"10.18773\/austprescr.2015.018","article-title":"Treatment for Alzheimer\u2019s disease: has anything changed?","volume":"38","author":"Waite","year":"2015","journal-title":"Aust Prescr."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0755","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11940-016-0422-5","article-title":"Progressive supranuclear palsy and corticobasal degeneration: pathophysiology and treatment options","volume":"18","author":"Lamb","year":"2016","journal-title":"Curr Treat Options Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0760","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/DDDT.S138828","article-title":"Review of deutetrabenazine: a novel treatment for chorea associated with Huntington\u2019s disease","volume":"12","author":"Dean","year":"2018","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0765","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/mds.25500","article-title":"Pharmacological treatment of chorea in Huntington\u2019s disease. Good clinical practice versus evidence-based guideline","volume":"28","author":"Reilman","year":"2013","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0770","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2015.8.FOCUS15328","article-title":"Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy","volume":"39","author":"Manix","year":"2015","journal-title":"Neurosurg Focus."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0775","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/421385","article-title":"Apathy in Alzheimer\u2019s disease: any effective treatment?","volume":"2014","author":"Rea","year":"2014","journal-title":"ScientificWorldJournal."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0780","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S1041610217001892","article-title":"Treatment effects of Ginkgo biloba extract EGb 761\u00ae on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials","volume":"30","author":"Savaskan","year":"2018","journal-title":"Int Psychogeriatr."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0785","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11940-016-0425-2","article-title":"Treatment of inappropiate sexual behavior in dementia","volume":"18","author":"De Giorgi","year":"2016","journal-title":"Curr Treat Options Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0790","doi-asserted-by":"crossref","unstructured":"Reus VI, Fochtmann LJ, Eyler E, Hilty DM, Horvitz-Lennon M, Jibson MD, et al. The American Psychiatric Association Practice Guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. 2016 (Acceso al texto completo: https:\/\/psychiatryonline.org\/doi\/pdf\/10.1176\/appi.books.9780890426807.","DOI":"10.1176\/appi.ajp.2015.173501"},{"key":"10.1016\/j.nrleng.2019.03.027_bib0795","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cns.12484","article-title":"Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"22","author":"Cummings","year":"2016","journal-title":"CNS Neurosci Ther."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0800","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0149-2918(04)90172-5","article-title":"Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer\u2019s disease","volume":"26","author":"Finkel","year":"2004","journal-title":"Clin Ther."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0805","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14656566.2018.1445721","article-title":"Pharmacological interventions for psychosis in Parkinson\u2019s disease patients","volume":"19","author":"Friedman","year":"2018","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0810","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0037-1602422","article-title":"Recognizing atypical Parkinsonisms: \u201cRed flags\u201d and therapeutic approaches","volume":"37","author":"McFarland","year":"2017","journal-title":"Semin Neurol."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0815","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10072-018-3628-3","article-title":"Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson\u2019s disease","volume":"40","author":"Bianchi","year":"2019","journal-title":"Neurol Sci."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0820","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/mds.23738","article-title":"The effects of rasagiline on cognitive d\u00e9ficits in Parkinson\u2019s disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study","volume":"26","author":"Hanagasi","year":"2011","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0825","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","article-title":"Miglustat in patients with Niemann-Pick disease type C (NP-C): A multicenter observational retrospective cohort study","volume":"98","author":"Pineda","year":"2009","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0830","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/WNL.0000000000005055","article-title":"Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia","volume":"90","author":"Zesiewicz","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0835","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/mds.27344","article-title":"Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies","volume":"33","author":"Palma","year":"2018","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0840","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: mild cognitive impairment. Report of the Guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0845","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jalz.2016.09.008","article-title":"Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia","volume":"13","author":"Simonsen","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrleng.2019.03.027_bib0850","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer\u2019s fluid bioarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol."}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580821000729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580821000729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:34:34Z","timestamp":1761881674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580821000729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":170,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2173580821000729"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2019.03.027","relation":{},"ISSN":["2173-5808"],"issn-type":[{"type":"print","value":"2173-5808"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Degenerative dementias: a question of syndrome or disease?","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2019.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2019.03.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}